<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ncl" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ncl</book-part-id>
      <title-group>
        <title>Neuronal Ceroid-Lipofuscinoses</title>
        <alt-title alt-title-type="alt-title">Synonym: Batten Disease</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mole</surname>
            <given-names>Sara E</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>MRC Laboratory for Molecular Cell Biology and UCL Institute of Child Health<break/>University College London <break/>London, United Kingdom</aff>
          <email>s.mole@ucl.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Williams</surname>
            <given-names>Ruth E</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Consultant Paediatric Neurologist, Department of Paediatric Neurology<break/>The Evelina Children's Hospital<break/>Guy&#x02019;s and St Thomas&#x02019; NHS Foundation Trust<break/>London, United Kingdom</aff>
          <email>ruth.williams@gstt.nhs.uk</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>10</day>
          <month>10</month>
          <year>2001</year>
        </date>
        <date date-type="updated">
          <day>1</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date date-type="revised">
          <day>15</day>
          <month>8</month>
          <year>2005</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="nf2" document-type="chapter">Neurofibromatosis 2</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="bcns" document-type="chapter">Nevoid Basal Cell Carcinoma Syndrome</related-object>
      <abstract id="ncl.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The neuronal ceroid-lipofuscinoses (NCLs) are a group of inherited, neurodegenerative, lysosomal storage disorders characterized by progressive intellectual and motor deterioration, seizures, and early death. Visual loss is a feature of most forms. Clinical phenotypes have been characterized traditionally according to the age of onset and order of appearance of clinical features into infantile, late-infantile, juvenile, adult, and Northern epilepsy (also known as progressive epilepsy with mental retardation [EPMR]). There is however genetic and allelic heterogeneity; a proposed new nomenclature and classification system has been developed to take into account both the responsible gene and the age at disease onset; for example, CLN1 disease, infantile onset and CLN1 disease, juvenile onset are both caused by pathogenic variants in <italic toggle="yes">PPT1</italic> but with differing age of onset.</p>
          <p>The most prevalent NCLs are CLN3 disease, classic juvenile and CLN2 disease, classic late infantile (although prevalence varies by ethnicity and country of family origin):</p>
          <p>CLN2 disease, classic late infantile. The first symptoms typically appear between age two and four years, usually starting with epilepsy, followed by regression of developmental milestones, myoclonic ataxia, and pyramidal signs. Visual impairment typically appears at age four to six years and rapidly progresses to light /dark awareness only. Life expectancy ranges from age six years to early teenage.</p>
          <p>CLN3 disease, classic juvenile. Onset is usually between ages four and ten years. Rapidly progressing visual loss resulting in severe visual impairment within one to two years is often the first clinical sign. Epilepsy with generalized tonic-clonic seizures and/or complex-partial seizures typically appears around age ten years. Life expectancy ranges from the late teens to the 30s.</p>
          <p>Other forms of NCL may present with behavior changes, epilepsy, visual impairment, or slowing of developmental progress and then loss of skills. The course may be extremely variable. Some genotype-phenotype information is available.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of an NCL is increasingly based on assay of enzyme activity and molecular genetic testing. In unusual cases diagnosis relies on electron microscopy (EM) of biopsied tissues. The diagnostic testing strategy in a proband depends on the age of onset. Pathogenic variants in thirteen genes &#x02014; <italic toggle="yes">PPT1</italic>, <italic toggle="yes">TPP1</italic>, <italic toggle="yes">CLN3</italic>, <italic toggle="yes">CLN5</italic>, <italic toggle="yes">CLN6</italic>, <italic toggle="yes">MFSD8, CLN8, CTSD, DNAJC5, CTSF, ATP13A2, GRN, KCTD7</italic> &#x02014; are known to cause NCL.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment is currently symptomatic and palliative only. Seizures, malnutrition, gastroesophageal reflux, pneumonia, sialorrhea, depression and anxiety, spasticity, Parkinsonian symptoms, and dystonia can be effectively managed. Antiepileptic drugs (AEDs) should be selected with caution. Benzodiazepines may help control seizures, anxiety, and spasticity. Trihexyphenydate may improve dystonia and sialorrhea. Individuals with swallowing problems may benefit from placement of a gastric (G) tube. Antidepressants and antipsychotic agents are sometimes indicated for those with CLN3 disease.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine medical management of children and young adults with complex neurodisability will be relevant to all those affected by NCL, and may include surveillance for swallowing difficulties and recurrent aspiration; radiograph surveillance of hip joints and spine; screening ECG for those with CLN3 disease who are older than age 16 years.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Carbamazepine and phenytoin may increase seizure activity and myoclonus and result in clinical deterioration; lamotrigine may exacerbate seizures and myoclonus, especially in CLN2 disease.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>The NCLs are inherited in an autosomal recessive manner with the exception of adult onset, which can be inherited in either an autosomal recessive or an autosomal dominant manner.</p>
          <p>Autosomal recessive NCL. The parents of a child with an autosomal recessive form of NCL are obligate heterozygotes, and therefore carry one mutated allele. Heterozygotes have no symptoms. At conception, each sib has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives is possible if the pathogenic variants in the family are known.</p>
          <p>Prenatal testing for pregnancies at increased risk is possible if the proband has documented deficient enzyme activity or if the pathogenic variant(s) have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ncl.Diagnosis">
        <title>Diagnosis</title>
        <p><xref ref-type="bibr" rid="ncl.REF.schulz.2013">Schulz et al [2013]</xref> provides a diagnostic algorithm for the neuronal ceroid-lipofuscinoses (NCLs).</p>
        <sec id="ncl.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Clinically, the NCLs are characterized by the following (<xref ref-type="table" rid="ncl.T.ncl_phenotypes_and_their_known_ass">Table 1</xref>):</p>
          <list list-type="bullet">
            <list-item>
              <p>Seizures</p>
            </list-item>
            <list-item>
              <p>Progressive deterioration of cognition (dementia)</p>
            </list-item>
            <list-item>
              <p>Motor function impairment (involuntary movements, myoclonus in younger children, ataxia, spasticity)</p>
            </list-item>
            <list-item>
              <p>Vision loss</p>
            </list-item>
          </list>
          <p>The first presenting symptom may vary among NCL phenotypes, which are typically distinguished on the basis of age of onset and clinical manifestations. Unusual pathogenic variants in many, if not all, NCL-associated genes may result in a milder or more severe disease phenotype.</p>
          <table-wrap id="ncl.T.ncl_phenotypes_and_their_known_ass" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>NCL Phenotypes and Their Known Associated Genes</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" rowspan="2" valign="middle" colspan="2" align="left" scope="colgroup" headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1">Phenotype</th>
                  <th id="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Phenotype by Gene and Onset</th>
                  <th id="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3">Presenting Findings&#x000a0;<sup>1</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2" id="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Proportion</th>
                  <th headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2" id="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2" id="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age of Onset</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Congenital</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Minor</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSD</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Before or around birth</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sz<break/>Microcephaly</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" rowspan="2" valign="middle" colspan="2" align="left" scope="row">Infantile (INCL)</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Major</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">PPT1</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">6-24 mos</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Cognitive/motor decline<break/>&#x02193;VA<break/>Sz</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Rare</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">KCTD7</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" rowspan="7" valign="middle" align="left" scope="row" colspan="1">Late-infantile (LINCL)</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">Classic</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Major</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">TPP1</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">2-4 yrs</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sz<break/>Motor/cognitive decline<break/>&#x02193;VA</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" rowspan="6" valign="middle" colspan="1" align="left" scope="row">Variant</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Major in Finland; <break/>minor elsewhere</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN5</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">4-7 yrs</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Cognitive/motor decline<break/>Sz<break/>&#x02193;VA</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Minor</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN6</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">18 mos - 8 yrs</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Cognitive/motor decline<break/>Sz<break/>&#x02193;VA</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Minor</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MFSD8</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Cognitive/motor decline<break/>Sz<break/>&#x02193;VA</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Minor</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN8</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">3-7.5 yrs</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Motor decline<break/>Sz<break/>&#x02193;VA</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Rare</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSD</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Minor</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">PPT1</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" rowspan="5" valign="middle" align="left" scope="row" colspan="1">Juvenile (JNCL)</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">Classic</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Major</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN3</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" rowspan="4" valign="middle" align="left" colspan="1">4-10 yrs</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">&#x02193;VA<break/>Sz<break/>Cognitive/motor decline, neuropsychiatric</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" rowspan="4" valign="middle" colspan="1" align="left" scope="row">Variant</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Minor</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">PPT1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Rare</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">TPP1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Rare</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">CLN9&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Rare</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">ATP13A2</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Northern epilepsy (NE) <break/>(progressive epilepsy with <break/>mental retardation [EPMR])</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Major in Finland, rare elsewhere</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN8</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">5-10 yrs</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sz<break/>Cognitive decline<break/>Sometimes &#x02193;VA</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Adult (ANCL) (Kufs disease)</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSD, PPT1, CLN3, CLN5, CLN6, CTSF, GRN</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">15-50 yrs</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Cognitive/motor decline<break/>Sz (type A); behavior abnormalities (type B)</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Adult (ANCL) (Parry disease); autosomal dominant</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">DNAJC5</italic>
                  </td>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_2 hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_ncl.T.ncl_phenotypes_and_their_known_ass_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ncl.TF.1.1">
                <label>1. </label>
                <p>Cognitive/motor decline, vision loss (&#x02193;VA), and seizures (Sz) are listed in the order in which they are most likely to occur in each phenotype.</p>
              </fn>
              <fn id="ncl.TF.1.2">
                <label>2. </label>
                <p>Locus name; gene unknown</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="ncl.Testing">
          <title>Testing</title>
          <p><bold>Histologic findings.</bold> Electron microscopy (EM) studies can be performed with 5-10 mL of heparinized whole blood (lymphocytes) or tissue biopsies (now usually of skin, but previously of conjunctiva or other tissues). EM studies (<xref ref-type="table" rid="ncl.T.electron_microscopic_findings_and">Table 2</xref>) remain essential in the non-classical NCL types, and show the presence of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Granular osmiophilic deposits (GROD) in CLN1 disease and CLN10/<italic toggle="yes">CTSD</italic> forms</p>
            </list-item>
            <list-item>
              <p>Predominantly curvilinear profiles (CVB) in CLN2 disease</p>
            </list-item>
            <list-item>
              <p>Fingerprint profiles (FP) in CLN3 disease</p>
            </list-item>
            <list-item>
              <p>Mixed-type inclusions (CVB, FP, and GROD) in CLN5, CLN6, MFSD8, CLN8, and other late-infantile and adult variant forms</p>
            </list-item>
          </list>
          <p>Note: The appearance of the pathologic inclusions can depend on the tissue examined.</p>
          <p><bold>Enzyme activity.</bold> Three lysosomal enzymes (<xref ref-type="table" rid="ncl.T.electron_microscopic_findings_and">Table 2</xref>) have been identified as being deficient in the neuronal ceroid-lipofuscinoses in white blood cells, fibroblasts, and chorionic villi:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Palmitoyl-protein thioesterase 1 (PPT-1)</bold> encoded by <italic toggle="yes">PPT1.</italic> A fluorimetric assay for PPT-1 based on the fluorochrome 4-methylumbelliferone detects significantly reduced PPT-1 activity in leukocytes, fibroblasts, lymphoblasts, amniotic fluid cells, or chorionic villi in forms of NCL caused by <italic toggle="yes">PPT1</italic> pathogenic variants [<xref ref-type="bibr" rid="ncl.REF.voznyi.1999.471">Voznyi et al 1999</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Tripeptidyl-peptidase 1 (TPP-1)</bold> encoded by <italic toggle="yes">TPP1</italic>. Individuals with <italic toggle="yes">TPP1</italic> pathogenic variants usually have significantly reduced enzymatic activity in leukocytes, fibroblasts, amniotic fluid cells, or chorionic villi [<xref ref-type="bibr" rid="ncl.REF.junaid.1999.169">Junaid et al 1999</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Cathepsin D (CTSD)</bold> encoded by <italic toggle="yes">CTSD</italic><bold>.</bold> Individuals with <italic toggle="yes">CTSD</italic> pathogenic variants usually have significantly reduced enzymatic activity in leukocytes or fibroblasts.</p>
            </list-item>
          </list>
          <p>A carrier of a pathogenic variant in <italic toggle="yes">PPT1</italic>, <italic toggle="yes">TPP1,</italic> or <italic toggle="yes">CTSD</italic> typically has 50% of normal enzymatic activity in PPT-1 or TPP-1 or CTSD, respectively [<xref ref-type="bibr" rid="ncl.REF.das.1998.361">Das et al 1998</xref>, <xref ref-type="bibr" rid="ncl.REF.zhong.1998.234">Zhong et al 1998</xref>, <xref ref-type="bibr" rid="ncl.REF.sleat.1999.1511">Sleat et al 1999</xref>, <xref ref-type="bibr" rid="ncl.REF.zhong.2000a.312">Zhong et al 2000a</xref>].</p>
          <table-wrap id="ncl.T.electron_microscopic_findings_and" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Electron Microscopic Findings and Enzyme Activity by NCL Genotype</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Locus Name</th>
                  <th id="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathologic Diagnosis on EM&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Lymphocytes</th>
                  <th id="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Enyzme Activity</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN1</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">PPT1</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">GROD</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">PPT-1 deficient</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN2</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">TPP1</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CVB</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">TPP-1 deficient</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN3</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN3</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">FP</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" rowspan="6" valign="middle" align="left" colspan="1">Not applicable</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN4</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">DNAJC5</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">GROD, mixed&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN5</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN5</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">FP</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN6</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN6</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CVB, FP, RL</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN7</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MFSD8</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CVB, FP, RL</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN8</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN8</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CVB- or GROD-like structures</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not usually vacuolated</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN9</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">GROD, CVB</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown; probably not applicable</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN10</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSD</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">GROD</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">CTSD deficient</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN11</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">GRN</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">FP</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Not applicable</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN12</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">ATP13A2</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">GROD, Mixed</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Not applicable</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN13</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSF</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">FP or none</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">CTSF-deficient</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CLN14</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">KCTD7</italic>
                  </td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">GROD, FP</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not vacuolated</td>
                  <td headers="hd_h_ncl.T.electron_microscopic_findings_and_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Not applicable</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>CVB = curvilinear profiles</p>
              </fn>
              <fn>
                <p>EM = electron microscopy</p>
              </fn>
              <fn>
                <p>FP = fingerprint profiles</p>
              </fn>
              <fn>
                <p>GROD = granular osmophilic deposits</p>
              </fn>
              <fn>
                <p>PPT-1 = palmitoyl-protein thioesterase 1</p>
              </fn>
              <fn>
                <p>RL = rectilinear complex</p>
              </fn>
              <fn>
                <p>TPP-1 = tripeptidyl peptidase 1</p>
              </fn>
              <fn id="ncl.TF.2.1">
                <label>1. </label>
                <p>In individuals with adult-onset disease, peripheral storage by EM may not be detected.</p>
              </fn>
              <fn id="ncl.TF.2.2">
                <label>2. </label>
                <p>Mixed = CVB, FP, RL, GROD</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <sec id="ncl.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold>
<italic toggle="yes">PPT1</italic>, <italic toggle="yes">TPP1</italic>, <italic toggle="yes">CLN3</italic>, <italic toggle="yes">DNAJC5, CLN5</italic>, <italic toggle="yes">CLN6</italic>, <italic toggle="yes">CLN7</italic>/<italic toggle="yes">MFSD8,</italic>
<italic toggle="yes">CLN8, CTSD, GRN, ATP13A2, CTSF, KCTD7</italic> are the genes in which pathogenic variants are known to cause the neuronal ceroid-lipofuscinoses.</p>
            <p>
              <bold>Evidence for locus heterogeneity</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>CLN9.</bold> The gene has not been identified in the families assigned this locus.</p>
              </list-item>
            </list>
            <table-wrap id="ncl.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in NCL</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Gene and Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">PPT1</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="table" rid="ncl.T.ppt1_pathogenic_variants_discussed">p.Arg122Trp</xref>&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Finnish: 98%&#x000a0;<sup>5</sup><break/>Non-Finnish: 10%&#x000a0;<sup>6</sup> for the targeted variant</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><xref ref-type="table" rid="ncl.T.ppt1_pathogenic_variants_discussed">p.Arg151Ter</xref>&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">60%&#x000a0;<sup>6</sup> for the targeted variant</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;98%&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exon and whole-gene deletions</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">TPP1</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="table" rid="ncl.T.tpp1_pathogenic_variants_discussed">c.509-1G&#x0003e;C, p.Arg208Ter</xref>&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">60%-90%&#x000a0;<sup>9</sup> for the targeted variant</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">97%&#x000a0;<sup>9</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">CLN3</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="table" rid="ncl.T.cln3_pathogenic_variants_discussed">c.461-280_677+382del</xref>&#x000a0;<sup>10</sup> (1-kb deletion)</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">96%&#x000a0;<sup>11</sup> for the targeted c.461-280_677+382del deletion</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;98%&#x000a0;<sup>11</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">DNAJC5</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known, estimate &#x0003e;95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">CLN5</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <xref ref-type="table" rid="ncl.T.cln5_pathogenic_variants_discussed">p.Tyr392Ter</xref>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">94% (Finnish ancestry)&#x000a0;<sup>12</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Est. 90%-95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exon and whole-gene deletions</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">CLN6</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">92%&#x000a0;<sup>13</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exon and whole-gene deletions</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MFSD8</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known, est. &#x0003e;95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">CLN8</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <xref ref-type="table" rid="ncl.T.cln8_pathogenic_variants_discussed">p.Arg24Gly</xref>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">~100% (Finnish ancestry)&#x000a0;<sup>14</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Est. 90%-95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exon and whole-gene deletions</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">CTSD</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known, est. &#x0003e;95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">GRN</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known, est. &#x0003e;95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">ATP13A2</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known, est. &#x0003e;95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">CTSF</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known, est. &#x0003e;95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">KCTD7</italic>
                    </td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_ncl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not known, est. &#x0003e;95%</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>See <xref ref-type="table" rid="ncl.T.ncl_phenotypes_and_their_known_ass">Table 1</xref> for phenotypes associated with pathogenic variants in each gene.</p>
                </fn>
                <fn id="ncl.TF.3.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="ncl" object-id="ncl.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="ncl.TF.3.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="ncl.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="ncl.TF.3.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene: % of individuals with at least one identifiable variant</p>
                </fn>
                <fn id="ncl.TF.3.4">
                  <label>4. </label>
                  <p>Pathogenic variant(s) included in targeted analysis may vary among laboratories.</p>
                </fn>
                <fn id="ncl.TF.3.5">
                  <label>5. </label>
                  <p>PPT-1 enzyme-deficient individuals with INCL [<xref ref-type="bibr" rid="ncl.REF.bellizzi.2000.4573">Bellizzi et al 2000</xref>]</p>
                </fn>
                <fn id="ncl.TF.3.6">
                  <label>6. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="ncl.TF.3.7">
                  <label>7. </label>
                  <p>PPT-1 enzyme-deficient individuals [<xref ref-type="bibr" rid="ncl.REF.das.1998.361">Das et al 1998</xref>, <xref ref-type="bibr" rid="ncl.REF.hofmann.1999.234">Hofmann et al 1999</xref>]</p>
                </fn>
                <fn id="ncl.TF.3.8">
                  <label>8. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="ncl.TF.3.9">
                  <label>9. </label>
                  <p>TPP-1 enzyme-deficient individuals with LINCL [<xref ref-type="bibr" rid="ncl.REF.zhong.1998.234">Zhong et al 1998</xref>, <xref ref-type="bibr" rid="ncl.REF.hartikainen.1999.162">Hartikainen et al 1999</xref>, <xref ref-type="bibr" rid="ncl.REF.lauronen.1999.360">Lauronen et al 1999</xref>, <xref ref-type="bibr" rid="ncl.REF.sleat.1999.1511">Sleat et al 1999</xref>, <xref ref-type="bibr" rid="ncl.REF.zhong.2000b.243">Zhong et al 2000b</xref>]</p>
                </fn>
                <fn id="ncl.TF.3.10">
                  <label>10. </label>
                  <p>Common deletion of exons 7 and 8 (see <xref ref-type="sec" rid="ncl.Molecular_Genetics">Molecular Genetics</xref>)</p>
                </fn>
                <fn id="ncl.TF.3.11">
                  <label>11. </label>
                  <p>Individuals with JNCL [<xref ref-type="bibr" rid="ncl.REF.munroe.1997.310">Munroe et al 1997</xref>, <xref ref-type="bibr" rid="ncl.REF.mao.2003.351">Mao et al 2003</xref>, <xref ref-type="bibr" rid="ncl.REF.mole.2004.399">Mole et al 2004</xref>, <xref ref-type="bibr" rid="ncl.REF.leman.2005.544">Leman et al 2005</xref>]</p>
                </fn>
                <fn id="ncl.TF.3.12">
                  <label>12. </label>
                  <p>Individuals of Finnish ancestry have variant LINCL and the <italic toggle="yes">CLN5</italic> pathogenic variant (<xref ref-type="table" rid="ncl.T.cln5_pathogenic_variants_discussed">p.Tyr392Ter</xref>) [<xref ref-type="bibr" rid="ncl.REF.savukoski.1998.286">Savukoski et al 1998</xref>]</p>
                </fn>
                <fn id="ncl.TF.3.13">
                  <label>13. </label>
                  <p>Families with vLINCL with linkage to <italic toggle="yes">CLN6</italic> [<xref ref-type="bibr" rid="ncl.REF.gao.2002.324">Gao et al 2002</xref>, <xref ref-type="bibr" rid="ncl.REF.sharp.2003.35">Sharp et al 2003</xref>, <xref ref-type="bibr" rid="ncl.REF.teixeira.2003.502">Teixeira et al 2003</xref>]</p>
                </fn>
                <fn id="ncl.TF.3.14">
                  <label>14. </label>
                  <p>For individuals of Finnish ancestry [<xref ref-type="bibr" rid="ncl.REF.ranta.2001">Ranta et al 2001</xref>, <xref ref-type="bibr" rid="ncl.REF.ranta.2004.300">Ranta et al 2004</xref>]</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="ncl.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>The testing strategy to confirm/establish the diagnosis in a proband</bold> depends on the age of onset, and is summarized in <xref ref-type="table" rid="ncl.T.diagnostic_algorithm_for_ncl_disea">Table 4</xref>.</p>
          <p>If EM indicates typical NCL storage material, all NCL-related genes may eventually need to be tested by enzymatic activity or by sequencing.</p>
          <table-wrap id="ncl.T.diagnostic_algorithm_for_ncl_disea" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Diagnostic Algorithm for NCL Diseases</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Presentation</th>
                  <th id="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Diagnostic Algorithm</th>
                  <th id="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene(s) for which Molecular Genetic Testing Should be Considered</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">Newborn with epilepsy and microcephaly</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Enzyme testing for CTSD (leukocytes or fibroblasts)</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If CTSD deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSD</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" rowspan="2" valign="middle" colspan="1" align="left" scope="row">If CTSD enzyme activity is normal, consider enzyme assay for PPT-1 and TPP-1.</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If PPT-1 deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">PPT1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If TPP-1 deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">TPP1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">Young child (&#x0003e;6 months) with developmental standstill or regression and/or newly occurring severe epilepsy of unknown cause</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">Enzyme testing for PPT-1 and TPP-1 (dry blood spots or leukocytes or fibroblasts)</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If PPT-1 deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">PPT1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If TPP-1 deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">TPP1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" rowspan="2" valign="middle" colspan="1" align="left" scope="row">If PPT-1 and TPP-1 enzyme activities are normal, electron microscopic examination (skin biopsy or lymphocytes)</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">If storage material is present:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">CLN5, CLN6, MFSD8, CLN8, KCTD7</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_1" rowspan="6" valign="middle" align="left" colspan="1">School child with visual loss and/or dementia and epilepsy</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Search for lymphocyte vacuoles (light microscopy of blood smear).</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If lymphocyte vacuoles are present:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CLN3</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" rowspan="3" valign="middle" colspan="1" align="left" scope="row">If no lymphocyte vacuoles, enzyme testing for PPT-1, TPP-1 and CTSD</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If PPT-1 deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">PPT1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If TPP-1 deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">TPP1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If CTSD deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSD</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If PPT-1 and TPP-1 enzyme activities are normal, electron microscopic examination (skin biopsy or lymphocytes)</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If storage material is present:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">CLN5, CLN6,</italic>
<italic toggle="yes">MFSD8</italic>, <italic toggle="yes">CLN8</italic>, <italic toggle="yes">ATP13A2</italic></td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_1" rowspan="6" valign="middle" align="left" scope="row" colspan="1">Young adult with non-specific mental, motor, or behavioral abnormalities</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" rowspan="4" valign="middle" align="left" colspan="1">Enzyme testing for PPT-1, TPP-1, CTSD, and CTSF</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If PPT-1 deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">PPT1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If TPP-1 deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">TPP1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If CTSD deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSD</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If CTSF deficient:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">CTSF</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" rowspan="2" valign="middle" colspan="1" align="left" scope="row">If enzyme activities are normal, electron microscopic examination (skin biopsy or lymphocytes).<break/>If storage material is present, genetic testing (eventually in special cases even without detection of storage material); consider possible mode of inheritance.</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If autosomal dominant:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">DNAJC5</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">If autosomal recessive:</td>
                  <td headers="hd_h_ncl.T.diagnostic_algorithm_for_ncl_disea_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">CLN6</italic>, <italic toggle="yes">GRN</italic>, <italic toggle="yes">CTSF</italic></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Adapted from <xref ref-type="bibr" rid="ncl.REF.schulz.2013">Schulz et al [2013]</xref>; reprinted with permission from Elsevier</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Carrier testing for relatives</bold> at risk for the autosomal recessive forms of NCL requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for an autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant(s) in the family.</p>
          <p><bold>Enzymatically or genetically undefined cases</bold>. Store DNA and fibroblast cell lines and consult an NCL research scientist who may be able to access new research tests, or store samples until diagnostic tests become available.</p>
          <p>Note: Cell banking is the storage of cell lines (typically derived from a skin biopsy) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking cells particularly when all of the genes responsible have not yet been identified, not all pathogenic variants have been elucidated, or testing is available on a research or linkage basis only. These cells can also be used to supply unlimited DNA or RNA samples.</p>
        </sec>
      </sec>
      <sec id="ncl.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ncl.Clinical_Description">
          <title>Clinical Description</title>
          <p>All individuals with a neuronal ceroid-lipofuscinosis (NCL) have progressive decline, an evolving cognitive and motor disorder, and seizures. With the exception of adult neuronal ceroid-lipofuscinosis (ANCL) and Northern epilepsy (NE), NCL phenotypes are usually associated with progressive loss of vision.</p>
          <p>A direct correlation between the gene that is mutated and phenotype does not always exist (see <xref ref-type="table" rid="ncl.T.ncl_phenotypes_and_their_known_ass">Table 1</xref> and <xref ref-type="sec" rid="ncl.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>); for example, individuals with pathogenic variants in <italic toggle="yes">PPT1</italic> can present with four different phenotypes (infantile, late-infantile, juvenile, and adult onset). Nonetheless, describing the NCLs by clinical phenotype is useful for medical management and prognosis [<xref ref-type="bibr" rid="ncl.REF.das.1998.361">Das et al 1998</xref>, <xref ref-type="bibr" rid="ncl.REF.wi_niewski.1998a.106">Wi&#x0015b;niewski et al 1998a</xref>, <xref ref-type="bibr" rid="ncl.REF.wi_niewski.1999.248">Wi&#x0015b;niewski et al 1999</xref>, <xref ref-type="bibr" rid="ncl.REF.van_diggelen.2001.269">van Diggelen et al 2001</xref>, <xref ref-type="bibr" rid="ncl.REF.wi_niewski.2001.576">Wi&#x0015b;niewski et al 2001</xref>].</p>
          <sec id="ncl.CLN1_Disease_Classic_Infantile_previ">
            <title>CLN1 Disease, Classic Infantile (previously Classic Infantile NCL, INCL, Santavuori-Haltia)</title>
            <p>CLN1 disease usually presents between age six and 24 months. Onset before age six months and after age two years also occurs [<xref ref-type="bibr" rid="ncl.REF.das.1998.361">Das et al 1998</xref>, <xref ref-type="bibr" rid="ncl.REF.wi_niewski.1998a.106">Wi&#x0015b;niewski et al 1998a</xref>, <xref ref-type="bibr" rid="ncl.REF.wi_niewski.1999.248">Wi&#x0015b;niewski et al 1999</xref>, <xref ref-type="bibr" rid="ncl.REF.van_diggelen.2001.269">van Diggelen et al 2001</xref>, <xref ref-type="bibr" rid="ncl.REF.wi_niewski.2001.576">Wi&#x0015b;niewski et al 2001</xref>].</p>
            <p>Initial signs include: delayed development, myoclonic jerks, and/or seizures. In one series of 21 affected children, early signs were deceleration of head growth and specific electroencephalographic (EEG) changes (from age 13 months). Hand stereotypies resembling those seen in Rett syndrome are recognized. In a study of eight newly diagnosed children with INCL (ages 15-27 months), mild-to-moderate deterioration of intellectual ability was observed in all [<xref ref-type="bibr" rid="ncl.REF.riikonen.2000.1828">Riikonen et al 2000</xref>]. The children had speech problems and lost interest in playing and in toys, but remained interested in their surroundings. They had moderate motor dysfunction.</p>
            <p>Retinal blindness and seizures are evident by age two years. The ERG (electroretinogram) is unrecordable by age four years.</p>
            <p>Psychomotor abilities deteriorate rapidly. Life expectancy varies from age two to nine years.</p>
            <p>MRI findings are: variable cerebral atrophy; signal change in the thalami and basal ganglia; and thin, hyperintense, periventricular high-signal rims of white matter [<xref ref-type="bibr" rid="ncl.REF.riikonen.2000.1828">Riikonen et al 2000</xref>]. The progressive diffuse brain atrophy on MRI seen in children with INCL during the first four years of life then stabilizes.</p>
          </sec>
          <sec id="ncl.CLN2_Disease_Classic_Late_Infantile">
            <title>CLN2 Disease, Classic Late Infantile (previously Late-Infantile NCL, LINCL, Jansky-Bielschowsky Disease)</title>
            <p>The first symptoms of CLN2 disease typically appear between age two and four years, usually starting with epilepsy. Generalized tonic-clonic seizures, absences, and partial-onset seizures may be observed. Myoclonus becomes prominent after the onset of seizures. Sometimes slowing of developmental milestones is evident before the onset of seizures. Following the onset of seizures, previously acquired motor/language and cognitive skills are lost.</p>
            <p>Visual impairment appears between age four and six years and rapidly progresses to blindness.</p>
            <p>Affected children are usually bedridden by age six years; disabilities are severe and nursing care needs are considerable by mid-childhood. Life expectancy is between age six years and adolescence but can be longer [<xref ref-type="bibr" rid="ncl.REF.wi_niewski.1998a.106">Wi&#x0015b;niewski et al 1998a</xref>, <xref ref-type="bibr" rid="ncl.REF.wi_niewski.1999.248">Wi&#x0015b;niewski et al 1999</xref>].</p>
            <p>Early electroencephalogram (EEG) may show spikes in the occipital region in response to photic stimulation at 1-2 Hz. Electroretinogram (ERG) is usually abnormal at presentation and becomes undetectable soon thereafter. On occasion, the ERG may be normal at presentation [<xref ref-type="bibr" rid="ncl.REF.weleber.1998.580">Weleber 1998</xref>].</p>
            <p>Visual evoked potentials (VEPs) are enhanced for a long period and diminish in the final stage of the disease.</p>
            <p>MRI shows progressive cerebellar and cerebral atrophy with normal basal ganglia and thalami.</p>
            <p><bold>Variants of late-infantile NCL.</bold> Many variant types are caused by pathogenic variants in distinct genes (<xref ref-type="table" rid="ncl.T.ncl_phenotypes_and_their_known_ass">Table 1</xref>). Some variant types are associated with but not exclusive to certain ethnic origins.</p>
            <p>The clinical features of variant late-infantile NCL types may have typical characteristics, but in general overlap:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>CLN5 disease, variant late infantile.</bold> The onset of disease is usually ages 4.5 to seven years in Finland. Life expectancy is between 13 and 35 years.</p>
              </list-item>
              <list-item>
                <p><bold>CLN6 disease.</bold> Visual loss and seizures may be the initial signs and symptoms. In children with onset after age four years, epilepsy, ataxia, and myoclonus may be the initial features.</p>
              </list-item>
              <list-item>
                <p><bold>MFSD8/CLN7 disease.</bold> Visual loss and seizures may be the initial signs and symptoms. In children with onset after age four years, epilepsy, ataxia, and myoclonus may be the initial features.</p>
              </list-item>
              <list-item>
                <p><bold>CLN8 disease.</bold> Onset may be earlier, between age two and six years [<xref ref-type="bibr" rid="ncl.REF.sharp.2003.35">Sharp et al 2003</xref>].</p>
              </list-item>
              <list-item>
                <p>
                  <bold>Genetically undefined</bold>
                </p>
              </list-item>
            </list>
          </sec>
          <sec id="ncl.CLN3_Disease_previously_Classic_Juve">
            <title>CLN3 Disease (previously Classic Juvenile NCL, JNCL, Batten Disease, Spielmeyer-Vogt Disease)</title>
            <p>Onset is usually between age four and eight years (mean age ~5 years).</p>
            <p>Rapidly progressing vision loss is almost always the first clinical sign of the disease and may be the only sign for two to five years. Children become severely visually impaired within two to four years of the onset of vision loss. Ophthalmologic examination early in the course of JNCL may reveal macular changes only; gradually, typical signs of pan-retinal degeneration develop: pigmentary changes in the retinal periphery, vascular attenuation, and optic nerve pallor. ERG shows loss of photoreceptor function early on [<xref ref-type="bibr" rid="ncl.REF.weleber.1998.580">Weleber 1998</xref>].</p>
            <p>Epilepsy with generalized tonic-clonic seizures and/or focal-onset seizures typically appears between age nine and 18 years. The EEG shows nonspecific disorganization and spike-and-slow-wave complexes.</p>
            <p>Little variation is observed in the visual symptoms and seizures, but variation can occur in the progression of motor and intellectual deterioration. Speech disturbances (festinating stuttering, often mislabeled as echolalia) and slow decline in cognition occur around the time of onset of seizures.</p>
            <p>Behavioral problems, extrapyramidal signs, and sleep disturbance occur in the second decade. <xref ref-type="bibr" rid="ncl.REF.b_ckman.2005.25">B&#x000e4;ckman et al [2005]</xref> found that some individuals with JNCL experience multiple psychiatric problems including disturbed thoughts, attention problems, somatic complaints, and aggressive behavior. Depression was uncommon.</p>
            <p>There is recent evidence of cardiac involvement late in the disease: progressive cardiac involvement with repolarization disturbances, ventricular hypertrophy, and sinus node dysfunction [<xref ref-type="bibr" rid="ncl.REF.ostergaard.2011.1245">Ostergaard et al 2011</xref>].</p>
            <p>Most individuals with CLN3 disease live until the late teens or early 20s; some may live into their 30s.</p>
            <p>CT and MRI reveal cerebral, and to a lesser degree, cerebellar atrophy in the later stages (age &#x0003e;15 years).</p>
            <p><bold>Atypical JNCL.</bold> Individuals with atypical JNCL are often compound heterozygotes for <italic toggle="yes">CLN3</italic> pathogenic variants (<xref ref-type="table" rid="ncl.T.cln3_pathogenic_variants_discussed">c.461-280_677+382del</xref> and another pathogenic variant). For example, <xref ref-type="table" rid="ncl.T.cln3_pathogenic_variants_discussed">p.Glu295Lys</xref> is associated with a particularly protracted disease in which a high level of functioning can be maintained for several decades. In other examples onset of epilepsy was delayed for a decade or more. The cause of these phenotypic differences is unknown. All types with pathogenic variants in <italic toggle="yes">CLN3</italic> have visual failure but vary in the severity of seizures and other neurologic complications.</p>
            <p>JNCL variants are also caused by milder pathogenic variants in genes that usually cause a more severe NCL, in particular <italic toggle="yes">CLN1</italic>.</p>
            <p><bold>JNCL variant - CLN9.</bold> Two families in which the underlying gene is not known have been described [<xref ref-type="bibr" rid="ncl.REF.schulz.2004.342">Schulz et al 2004</xref>].</p>
          </sec>
          <sec id="ncl.Adult_NCL_ANCL">
            <title>Adult NCL (ANCL)</title>
            <p>Initial signs and symptoms usually appear around age 30 years, with death occurring about ten years later. Symptoms may appear as early as age 11 years or much later in adulthood. Ophthalmologic studies are normal.</p>
            <p>The two major clinical phenotypes are:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Type A,</bold> characterized by progressive myoclonic epilepsy with dementia, ataxia, and late-occurring pyramidal and extrapyramidal signs. Seizures are often uncontrollable. Individuals with this type have been found to have pathogenic variants in <italic toggle="yes">CLN6;</italic> it is now known as adult CLN6 disease.</p>
              </list-item>
              <list-item>
                <p><bold>Type B,</bold> characterized by behavior abnormalities and dementia, which may be associated with motor dysfunction, ataxia, extrapyramidal signs, and suprabulbar (brain stem) signs. Some families have been found to have pathogenic variants in <italic toggle="yes">CTSF</italic>.</p>
              </list-item>
            </list>
            <p>In the presenile form with onset after age 50 years, dementia, cognitive decline, motor dysfunction, seizures, and suprabulbar signs are observed as well as mixed inclusions on EM (<xref ref-type="table" rid="ncl.T.electron_microscopic_findings_and">Table 2</xref>).</p>
            <p>Autosomal dominant forms of adult-onset NCL have GROD observed on EM (<xref ref-type="table" rid="ncl.T.electron_microscopic_findings_and">Table 2</xref>) [<xref ref-type="bibr" rid="ncl.REF.burneo.2003.841">Burneo et al 2003</xref>, <xref ref-type="bibr" rid="ncl.REF.nijssen.2003.574">Nijssen et al 2003</xref>], with some having pathogenic variants in <italic toggle="yes">DNAJC5</italic>. The genetically defined cases of recessive adult-onset NCL include several individuals with deficient PPT-1 enzyme activity [<xref ref-type="bibr" rid="ncl.REF.van_diggelen.2001.269">van Diggelen et al 2001</xref>, <xref ref-type="bibr" rid="ncl.REF.ramadan.2007.387">Ramadan et al 2007</xref>], deficient CTSD enzyme activity [Author, unpublished], or pathogenic variants in <italic toggle="yes">CLN5</italic>. Adult-onset disease, previously known as Kufs disease type A, results from pathogenic variants in <italic toggle="yes">CLN6</italic> [<xref ref-type="bibr" rid="ncl.REF.arsov.2011.566">Arsov et al 2011</xref>]; some cases of Kufs disease type B result from reduced CTSF activity [<xref ref-type="bibr" rid="ncl.REF.smith.2013.1417">Smith et al 2013</xref>]. It is highly likely that a mild pathogenic variant in all known NCL-associated genes could delay disease onset until adulthood.</p>
          </sec>
          <sec id="ncl.Northern_Epilepsy_NE_Progressive_Epi">
            <title>Northern Epilepsy (NE, Progressive Epilepsy with Mental Retardation, EPMR)</title>
            <p>Northern epilepsy is a specific phenotype caused by a particular pathogenic variant in <italic toggle="yes">CLN8</italic>, and is characterized by epilepsy with tonic-clonic or complex-partial seizures, slow intellectual deterioration, and motor dysfunction.</p>
            <p>Vision problems are rare.</p>
            <p>The frequency of the epileptic manifestations decreases after puberty, but slow cognitive decline continues throughout life. Some individuals have lived beyond age 60 years.</p>
          </sec>
        </sec>
        <sec id="ncl.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Mutation of the following NCL-related genes can be associated with both early and late age of onset &#x02013; the latter probably the result of greater amounts of residual protein activity:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>CLN10</bold><italic toggle="yes">/</italic><bold><italic toggle="yes">CTSD.</italic></bold> Congenital, late-infantile, or teenage-/adult-onset NCL</p>
            </list-item>
            <list-item>
              <p><bold>CLN1</bold><italic toggle="yes">/</italic><bold><italic toggle="yes">PPT1.</italic></bold> Infantile, late-infantile, juvenile, and adult-onset NCL</p>
            </list-item>
            <list-item>
              <p><bold>CLN2</bold>/<bold><italic toggle="yes">TPP1</italic></bold><italic toggle="yes">.</italic> Late-infantile, juvenile, and possibly later-onset NCL</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">CLN5.</italic></bold> Late-infantile variant, juvenile, and adult-onset NCL</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">CLN6.</italic></bold> Late-infantile variant, and adult-onset NCL</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">CLN8.</italic></bold> Late-infantile variant NCL and EPMR</p>
            </list-item>
          </list>
          <p>Later ages of onset have not yet been described for <italic toggle="yes">CLN3</italic> or <italic toggle="yes">CLN7</italic>/<italic toggle="yes">MFSD8</italic>.</p>
        </sec>
        <sec id="ncl.Nomenclature">
          <title>Nomenclature</title>
          <p>Neuronal ceroid-lipofuscinoses nomenclature is now gene based [<xref ref-type="bibr" rid="ncl.REF.williams.2012.183">Williams &#x00026; Mole 2012</xref>].</p>
          <table-wrap id="ncl.T.former_ncl_nomenclature" orientation="portrait" position="anchor">
            <label>Table 5. </label>
            <caption>
              <p>Former NCL Nomenclature</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Eponym</th>
                  <th id="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease</th>
                  <th id="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">OMIM</th>
                  <th id="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Phenotype</th>
                  <th id="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Former Abbreviated Name</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Haltia-Santavuori</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN1</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/256730">256730</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Infantile classic</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">INCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Jansk&#x000fd;-Bielschowsky</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN2</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/204500">204500</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Late-infantile classic</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">LINCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Spielmeyer-Sj&#x000f6;gren</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN3</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/204200">204200</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Juvenile</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">JNCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Kufs type A</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN6</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/204300">204300</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Adult</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">ANCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Kufs type B</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN13</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Adult</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">ANCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Finnish variant late infantile</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN5</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/256731">256731</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Late-infantile variant</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">vLINCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Lake-Cavanagh or Indian variant late infantile</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN6</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/601780">601780</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Early-juvenile variant and late-infantile variant</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">vLINCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Turkish variant late infantile</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN7</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610951">610951</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Late-infantile variant</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">vLINCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Northern epilepsy/EPMR</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN8</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600143">600143</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">EPMR, late-infantile variant</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">vLINCL</td>
                </tr>
                <tr>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Parry</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CLN4</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/162350">162350</ext-link>
                  </td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Adult autosomal dominant</td>
                  <td headers="hd_h_ncl.T.former_ncl_nomenclature_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">ANCL</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Adapted from <xref ref-type="bibr" rid="ncl.REF.williams.2012.183">Williams &#x00026; Mole [2012]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Batten disease was originally used to refer only to what is now known to be classic CLN3 disease. However, more recently it is being used to provide an accessible name for all types of NCL, regardless of genetic alteration.</p>
        </sec>
        <sec id="ncl.Incidence_and_Prevalence">
          <title>Incidence and Prevalence</title>
          <p>Neuronal ceroid-lipofuscinoses (NCLs) are the most common hereditary progressive neurodegenerative disease with a prevalence of approximately 1.5 to nine per million population [<xref ref-type="bibr" rid="ncl.REF.mole.2011">Mole et al 2011</xref>].</p>
          <p>The incidence of NCL ranges in different countries from 1.3 to seven per 100,000 live births [<xref ref-type="bibr" rid="ncl.REF.mole.2011">Mole et al 2011</xref>].</p>
        </sec>
      </sec>
      <sec id="ncl.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">CTSD</italic>, <italic toggle="yes">PPT1</italic>, <italic toggle="yes">TPP1</italic>, <italic toggle="yes">DNAJC5</italic>, <italic toggle="yes">CLN5</italic>, <italic toggle="yes">CLN6</italic>, <italic toggle="yes">MFSD8,</italic> or <italic toggle="yes">CLN8.</italic></bold> No other phenotypes are associated with pathogenic variants in these genes.</p>
        <p><bold><italic toggle="yes">ATP13A2.</italic></bold> Pathogenic variants in <italic toggle="yes">ATP13A2</italic> may also be associated with Kufor-Rakeb syndrome.</p>
        <p><bold><italic toggle="yes">GRN</italic>.</bold> Heterozygous pathogenic variants in <italic toggle="yes">GRN</italic> may also be associated with frontotemporal lobar degeneration with TDP43 inclusions.</p>
        <p><bold><italic toggle="yes">KCTD7</italic>.</bold> Pathogenic variants in <italic toggle="yes">KCTD7</italic> may also be associated with progressive myoclonic epilepsy type 3 (EPM3).</p>
        <p><bold><italic toggle="yes">CLN3.</italic></bold> It is a possible that different phenotypes are associated with pathogenic variants other than the 1-kb deletion in <italic toggle="yes">CLN3</italic> [<xref ref-type="bibr" rid="ncl.REF.kitzm_ller.2008.303">Kitzm&#x000fc;ller et al 2008</xref>].</p>
      </sec>
      <sec id="ncl.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>In a UK epidemiologic study of progressive intellectual and neurologic deterioration over 12 years, 147 different diagnoses were recorded in 1114 of 2636 patients younger than age 16 years. The six most common groups of disorders were leukoencephalopathies (183 cases), neuronal ceroid-lipofuscinoses (141), mitochondrial disorders (122), mucopolysaccharidoses (102), gangliosidoses (100), and peroxisomal disorders (69) [<xref ref-type="bibr" rid="ncl.REF.verity.2010.361">Verity et al 2010</xref>].</p>
        <p><bold>CLN1 disease.</bold> Other progressive neurologic diseases with onset from birth to age two years need to be considered. These include: <related-object link-type="booklink" source-id="gene" document-id="tay-sachs" document-type="chapter">hexosaminidase A deficiency</related-object>, progressive leukodystrophies <related-object link-type="booklink" source-id="gene" document-id="rett" document-type="chapter">Rett syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="pbd" document-type="chapter">peroxisomal biogenesis disorders</related-object>, Neimann-Pick disease types A and B (see <related-object link-type="booklink" source-id="gene" document-id="npab" document-type="chapter">Acid Sphingomyelinase Deficiency</related-object>), and <related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter">Leigh syndrome</related-object> (see also <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>). While some of these disorders are associated with cortical blindness, retinal involvement is rarely seen.</p>
        <p><bold>CLN2 disease.</bold> Other progressive neurologic diseases with onset from ages two to four years need to be considered. These include: epileptic encephalopathies, other lysosomal storage disorders, <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">mitochondrial disease</related-object>, and leukodystrophies.</p>
        <p><bold>CLN3 disease.</bold> In the initial stage when individuals present with visual loss, <related-object link-type="booklink" source-id="gene" document-id="rp-overview" document-type="chapter">retinitis pigmentosa</related-object> (RP) or cone-rod dystrophy may be considered. The ophthalmologic involvement of JNCL differs from classic RP in that the vision loss in CLN3 disease is typically central at first (rather than peripheral) and rapidly progressive, with total blindness occurring in one to two years [<xref ref-type="bibr" rid="ncl.REF.weleber.1998.580">Weleber 1998</xref>]. In contrast, RP is indolent and progresses slowly over decades. Other disorders in which a cone-rod retinal dystrophy occurs are: <related-object link-type="booklink" source-id="gene" document-id="bbs" document-type="chapter">Bardet-Biedl syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="joubert" document-type="chapter">Joubert syndrome</related-object>, juvenile nephronophthisis, and <related-object link-type="booklink" source-id="gene" document-id="alstrom" document-type="chapter">Alstrom syndrome</related-object>, all of which can be distinguished from CLN3 disease by their clinical features.</p>
        <p><bold>Northern epilepsy (NE)</bold> needs to be distinguished from other neurologic conditions with seizures [<xref ref-type="bibr" rid="ncl.REF.zupanc.2004.156">Zupanc &#x00026; Legros 2004</xref>]. Myoclonus is not a feature of NE, and thus a large number of disorders with myoclonic seizures and intellectual disability can be excluded. The clinical course of NE differs from Landau-Kleffner syndrome, Rasmussen syndrome, and epilepsy with electric status epilepticus during slow sleep. <related-object link-type="booklink" source-id="gene" document-id="tuberous-sclerosis" document-type="chapter">Tuberous sclerosis complex</related-object> and the Sturge-Weber syndrome can be distinguished from NE on the basis of clinical and neuroradiologic features. Lack of pyramidal or extrapyramidal signs and lack of cerebellar ataxia distinguish NE from degenerative disorders such as: juvenile <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="pkan" document-type="chapter">PKAN</related-object> (previously called Hallervorden-Spatz syndrome), juvenile GM2 gangliosidosis (see <related-object link-type="booklink" source-id="gene" document-id="tay-sachs" document-type="chapter">Hexosaminidase A deficiency</related-object>), <related-object link-type="booklink" source-id="gene" document-id="npc" document-type="chapter">Niemann-Pick disease type C</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gan" document-type="chapter">giant axonal neuropathy</related-object>, or neuronal intranuclear inclusion disease (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/603472">OMIM</ext-link>).</p>
        <p><bold>Adult Kuf&#x02019;s disease.</bold> The differential diagnosis includes progressive myoclonic epilepsies (see <related-object link-type="booklink" source-id="gene" document-id="lafora" document-type="chapter">Lafora Progressive Myoclonus Epilepsy</related-object>), <related-object link-type="booklink" source-id="gene" document-id="epm1" document-type="chapter">Unverricht-Lundborg disease</related-object>, mitochondrial disease including <related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object> (see also <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disease Overview</related-object>); early-onset dementias, Creutzfeldt-Jakob Disease (CJD) (see <related-object link-type="booklink" source-id="gene" document-id="prion" document-type="chapter">Genetic Prion Diseases</related-object>) and<related-object link-type="booklink" source-id="gene" document-id="drpla" document-type="chapter"> dentatorubral-pallidoluysian atrophy</related-object> (DRPLA).</p>
      </sec>
      <sec id="ncl.Management">
        <title>Management</title>
        <sec id="ncl.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with one of the neuronal ceroid-lipofuscinoses, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
            <list-item>
              <p>Developmental/cognitive and educational assessment</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="ncl.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Symptomatic treatment can be successful in mitigating the manifestations of NCL. Seizures, sleep-related problems, malnutrition, gastroesophageal reflux, pneumonia, sialorrhea, hyperactivity and behavior problems, psychosis, anxiety, spasticity, Parkinsonian symptoms, and dystonia can be palliated.</p>
          <p><bold>Seizures.</bold> Antiepileptic drugs (AEDs) should be selected with caution. The stage of the disease, age of the affected individual, and quality of life are important to consider in evaluating the effectiveness of AEDs.</p>
          <p>Lamotrigine (LTG) had a favorable effect on 23/28 individuals with JNCL, 13/19 being continued on monotherapy with 100% control, compared to 70% control for those receiving valproic acid (VPA), 60% control for VPA-clonazepam (CZP), and 60% control for LTG-CZP [<xref ref-type="bibr" rid="ncl.REF.aberg.1999.796">Aberg et al 1999</xref>, <xref ref-type="bibr" rid="ncl.REF.aberg.2000.1296">Aberg et al 2000</xref>].</p>
          <p>Other newer AEDs including levetiracetam and topiramate may also be beneficial [Author, personal experience].</p>
          <p><bold>Other.</bold> Benzodiazepines may be of benefit for seizures, anxiety, spasticity, and sleep disorders.</p>
          <p>Trihexyphenydil improves dystonia and sialorrhea.</p>
          <p>Individuals with swallowing problems may benefit from placement of a gastric (G) tube.</p>
          <p>Antidepressants and antipsychotic agents are sometimes indicated for those with CLN3 disease.</p>
        </sec>
        <sec id="ncl.Surveillance">
          <title>Surveillance</title>
          <p>Routine medical management of children and young adults with complex neurodisability will be relevant to all those affected by NCL. This may include clinical surveillance for the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Swallowing difficulties and recurrent aspiration</p>
            </list-item>
            <list-item>
              <p>X-ray surveillance of hip joints and spine</p>
            </list-item>
            <list-item>
              <p>Screening ECG for those individuals with CLN3 disease who are older than age 16 years</p>
            </list-item>
          </list>
        </sec>
        <sec id="ncl.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Carbamazepine (CZP) and phenytoin may increase seizure activity and myoclonus in NCL and result in clinical deterioration.</p>
          <p>Lamotrigine may exacerbate seizures and myoclonus especially in CLN2 disease.</p>
          <p>In a series of 60 individuals with JNCL, valproic acid (VPA) was withdrawn in 20% and clonazepam (CZP) in 16% because of side effects [<xref ref-type="bibr" rid="ncl.REF.aberg.2000.1296">Aberg et al 2000</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Fifty percent of individuals receiving VPA had sleep disturbances or excessive sedation.</p>
            </list-item>
            <list-item>
              <p>CZP stimulates salivation and respiratory secretions, increasing the risk for pneumonia in bedridden individuals, many of whom have gastroesophageal reflux. CZP is a sedative and can cause behavior disturbances.</p>
            </list-item>
          </list>
        </sec>
        <sec id="ncl.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="ncl.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ncl.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><xref ref-type="bibr" rid="ncl.REF.crystal.2004.1131">Crystal et al [2004]</xref> initiated gene therapy for children with LINCL caused by pathogenic variants in <italic toggle="yes">CLN2</italic>. They administered a replication-deficient adeno-associated virus (AAV) vector expressing human <italic toggle="yes">CLN2</italic> cDNA directly into the brains of children with either severe or moderate LINCL in an attempt to produce sufficient amounts of TPP-1, to prevent further loss of neurons and hence limit disease progression. The research is ongoing.</p>
          <p>Stem cell therapy for phenotypes caused by pathogenic variants in <italic toggle="yes">CLN1</italic> and <italic toggle="yes">CLN2</italic> is in progress [Author, personal communication].</p>
          <p>The drug EGIS-8332, which targets AMPA receptors, improved performance in a CLN3 disease mouse model. Trials in humans have not yet started. Talampanel (LY300164) is a drug which targets the same receptors and is being assessed in a clinical trial to treat epilepsy and Parkinson disease in humans. Plans to test this drug in a mouse model for CLN3 disease are underway at the University of Rochester Medical Center (Rochester, New York, USA).</p>
          <p>The University of Rochester Medical Center is also conducting a clinical trial using the immunosuppressant mycophenolate (mycophenolate mofetil, Cellcept<sup>&#x000ae;</sup>, Myfortic<sup>&#x000ae;</sup>, mycophenolate sodium or mycophenolic acid) in individuals with juvenile CLN3.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="ncl.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ncl.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>The NCLs are inherited in an autosomal recessive manner with the exception of adult NCL, which can be inherited in either an autosomal recessive or an autosomal dominant manner.</p>
        </sec>
        <sec id="ncl.Risk_to_Family_Members__Autosomal_Re">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one mutated allele). Obtaining parental samples to confirm carrier status is recommended once pathogenic variants have been identified in the proband.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of a proband has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Probands with INCL, LINCL, and classic JNCL do not reproduce.</p>
            </list-item>
            <list-item>
              <p>Very rarely, individuals with atypical JNCL reproduce [<xref ref-type="bibr" rid="ncl.REF.wi_niewski.1998b.36">Wi&#x0015b;niewski et al 1998b</xref>]. The offspring of an individual with NCL are obligate heterozygotes (carriers) for a mutated allele causing NCL.</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="ncl.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing by DNA analysis is possible once the pathogenic variants in the underlying gene have been identified in the family.</p>
        </sec>
        <sec id="ncl.Risk_to_Family_Members__Autosomal_Do">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance (adult NCL only)</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with autosomal dominant adult NCL have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with autosomal dominant adult NCL may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing of the identified variant. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome and/or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p>Note: Although most individuals diagnosed with autosomal dominant adult NCL have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk (for the disorder) because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the DNA of either parent, the risk to sibs is low, but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with autosomal dominant adult NCL has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="ncl.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ncl.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal testing is possible in pregnancies at increased risk if biochemical studies in the proband have revealed deficient activity of the enzyme CTSD, PPT-1, or the enzyme TPP-1, or if the pathogenic variant(s) have been identified in the proband and parents.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant(s) have been identified.</p>
        </sec>
      </sec>
      <sec id="ncl.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ncl.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="ncl.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Both human and animal forms of neuronal ceroid-lipofuscinoses can be divided into two major groups, based on the nature of the material accumulated in lysosomes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Those characterized by the prominent storage of saposins (SAPs) A and D; and</p>
            </list-item>
            <list-item>
              <p>Those showing the predominance of subunit c of mitochondrial ATP synthase accumulation.</p>
            </list-item>
          </list>
          <p>In addition to proteins, storage material in NCLs contains other components including lipids, metals, dolichyl pyrophosphoryl oligosaccharides, and lipid thioesters.</p>
          <p>The relation between genetic defects associated with the major NCL forms, the accumulation of storage material, and tissue dysfunction and/or damage is still unknown. Furthermore, all individuals with NCLs manifest lysosomal storage in many tissues and organs, but severe degeneration and cell loss involve mostly neuronal cells. Thus, it appears that NCL proteins may be most critical for the metabolism of neurons. It is uncertain whether this phenomenon results from the specific metabolic requirements of a neuron as a postmitotic cell, or from the properties of NCL proteins per se.</p>
          <p>The spectrum of pathogenic variants present in NCL is listed in the NCL Mutation Database <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ucl.ac.uk/ncl">www.ucl.ac.uk/ncl</ext-link> (see also <related-object source-id="gene" document-id="ncl" object-id="ncl.molgen.TA">Table A</related-object>).</p>
          <p>For a detailed summary of gene and protein information for the genes associated with NCLs, see <related-object source-id="gene" document-id="ncl" object-id="ncl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <sec id="ncl.PPT1">
            <title>
              <italic toggle="yes">PPT1</italic>
            </title>
            <p><bold>Gene structure.</bold> The gene comprises nine exons spanning 25 kb.</p>
            <p><bold>Pathogenic variants.</bold> More than 60 pathogenic variants of <italic toggle="yes">PPT1</italic> are known. The common pathogenic variants are p.Arg122Trp and p.Arg151Ter [<xref ref-type="bibr" rid="ncl.REF.das.1998.361">Das et al 1998</xref>]; the others are uncommon or private variants.</p>
            <table-wrap id="ncl.T.ppt1_pathogenic_variants_discussed" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p><italic toggle="yes">PPT1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ncl.T.ppt1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_ncl.T.ppt1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_ncl.T.ppt1_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ncl.T.ppt1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.364A&#x0003e;T</td>
                    <td headers="hd_h_ncl.T.ppt1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg122Trp</td>
                    <td headers="hd_h_ncl.T.ppt1_pathogenic_variants_discussed_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/50726955">NM_000310.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4506031">NP_000301.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.ppt1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.451C&#x0003e;T</td>
                    <td headers="hd_h_ncl.T.ppt1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg151Ter</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> PPT-1 is a globular enzyme consisting of six parallel &#x003b2; strands alternating with &#x003b1; helices organized in a structure known as the &#x003b1;/&#x003b2; hydrolast fold typical of lipases. A large insertion between &#x003b2;6 and &#x003b2;7 (amino acid residues 140-223) forms a second domain that forms most of the fatty acid-binding site. Catalytic active site residues are: Ser115, Asp233, and His289. PPT-1 is a housekeeping enzyme present in the lysosomes of many tissues. It removes long-chain fatty acids, usually palmitate, from cystine residues.</p>
            <p>Based on the results of crystallographic and molecular modeling studies of recombinant bovine PPT-1 enzyme, a mechanism has been hypothesized to explain the milder INCL phenotype in individuals with <italic toggle="yes">PPT1</italic> pathogenic variants who retain low-level thioesterase activity [<xref ref-type="bibr" rid="ncl.REF.bellizzi.2000.4573">Bellizzi et al 2000</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants affect PPT-1 in different ways. For some the protein is truncated, lacking its catalytic site; for others critical residues, such as within the catalytic site, are absent or altered.</p>
          </sec>
          <sec id="ncl.TPP1">
            <title>
              <italic toggle="yes">TPP1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">TPP1</italic> comprises 13 exons.</p>
            <p><bold>Pathogenic variants.</bold> More than 90 pathogenic variants of <italic toggle="yes">TPP1</italic> are known. The common pathogenic variants are p.Arg208Ter and c.509-1G&#x0003e;C [<xref ref-type="bibr" rid="ncl.REF.zhong.1998.234">Zhong et al 1998</xref>, <xref ref-type="bibr" rid="ncl.REF.sleat.1999.1511">Sleat et al 1999</xref>]; the others are uncommon or private variants.</p>
            <table-wrap id="ncl.T.tpp1_pathogenic_variants_discussed" orientation="portrait" position="anchor">
              <label>Table 7. </label>
              <caption>
                <p><italic toggle="yes">TPP1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ncl.T.tpp1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_ncl.T.tpp1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_ncl.T.tpp1_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ncl.T.tpp1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.622C&#x0003e;T</td>
                    <td headers="hd_h_ncl.T.tpp1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg208Ter</td>
                    <td headers="hd_h_ncl.T.tpp1_pathogenic_variants_discussed_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/118582287">NM_000391.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/5729770">NP_000382.3</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.tpp1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.509-1G&#x0003e;C<break/>(IVS5-1G&#x0003e;C)</td>
                    <td headers="hd_h_ncl.T.tpp1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="ncl.TF.7.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> TPP-1 comprises 365 amino acids. It is a lysosomal serine-carboxyl peptidase that sequentially removes N-terminal tripeptides from small peptides, including several peptide hormones.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants affect TPP-1 in different ways. For some the protein is truncated, lacking its catalytic site; for others critical residues, such as within the catalytic site, are absent or altered.</p>
          </sec>
          <sec id="ncl.CLN3">
            <title>
              <italic toggle="yes">CLN3</italic>
            </title>
            <p><bold>Gene structure.</bold> The gene comprises 15 exons.</p>
            <p><bold>Pathogenic variants.</bold> More than 50 pathogenic variants are presently known. The common pathogenic variant is c.461-280_677+382del [<xref ref-type="bibr" rid="ncl.REF.munroe.1997.310">Munroe et al 1997</xref>]; the others are uncommon or private variants. The c.461-280_677+382del variant deletes 217 bp of coding sequence, but the breakpoints are in intronic regions and the total deletion is approximately 1 kb and includes exons 7 and 8. The genomic DNA designation is NG_008654.1:g.10373_11338del.</p>
            <table-wrap id="ncl.T.cln3_pathogenic_variants_discussed" orientation="portrait" position="anchor">
              <label>Table 8. </label>
              <caption>
                <p><italic toggle="yes">CLN3</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ncl.T.cln3_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_ncl.T.cln3_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_ncl.T.cln3_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ncl.T.cln3_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.461-280_677+382del (c.461_677del)</td>
                    <td headers="hd_h_ncl.T.cln3_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly154AlafsTer29</td>
                    <td headers="hd_h_ncl.T.cln3_pathogenic_variants_discussed_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/109698600">NM_001042432.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/109698601">NP_001035897.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.cln3_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.88G&#x0003e;A</td>
                    <td headers="hd_h_ncl.T.cln3_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu295Lys</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="ncl.TF.8.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The protein comprises 438 amino acids; its function is unknown. <italic toggle="yes">CLN3</italic> is most likely to be present in the lysosomal/endosomal membrane, and may also be in the Golgi complex and on the plasma membrane. In addition, <italic toggle="yes">CLN3</italic> undergoes post-translational modification.</p>
            <p><bold>Abnormal gene product.</bold> Although the function of <italic toggle="yes">CLN3</italic> remains elusive, it is apparent that genetic alterations in <italic toggle="yes">CLN3</italic> may have a direct effect on lysosomal function. The most common pathogenic variant, the 1-kb deletion, does not completely abolish CLN3 function [<xref ref-type="bibr" rid="ncl.REF.kitzm_ller.2008.303">Kitzm&#x000fc;ller et al 2008</xref>].</p>
          </sec>
          <sec id="ncl.DNAJC5">
            <title>
              <italic toggle="yes">DNAJC5</italic>
            </title>
            <p><bold>Gene structure.</bold> The transcript has five exons [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_025219.2">NM_025219.2</ext-link>].</p>
            <p><bold>Pathogenic variants.</bold> Two pathogenic variants have been described [<xref ref-type="bibr" rid="ncl.REF.noskov_.2011.241">Noskov&#x000e1; et al 2011</xref>].</p>
            <p><bold>Normal gene product.</bold> The protein, DnaJ homolog subfamily C member 5, functions in many cellular processes by regulating the ATPase activity of 70-kd heat shock proteins [provided by RefSeq].</p>
            <p><bold>Abnormal gene product.</bold> Two variants that cause disease when present on a single allele of <italic toggle="yes">DNAJC5</italic> have been identified; the mechanism is unknown.</p>
          </sec>
          <sec id="ncl.CLN5">
            <title>
              <italic toggle="yes">CLN5</italic>
            </title>
            <p><bold>Gene structure.</bold> The gene comprises four exons.</p>
            <p><bold>Pathogenic variants.</bold> More than 30 pathogenic variants are known. The first affected individuals were in Finland; many cases have now been reported elsewhere. The pathogenic variant p.Tyr392Ter is observed in 94% of individuals of Finnish descent who have CLN5; the pathogenic variant p.Trp75Ter also segregates in affected individuals of Finnish descent. Other pathogenic variants are less common.</p>
            <table-wrap id="ncl.T.cln5_pathogenic_variants_discussed" orientation="portrait" position="anchor">
              <label>Table 9. </label>
              <caption>
                <p><italic toggle="yes">CLN5</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ncl.T.cln5_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_ncl.T.cln5_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_ncl.T.cln5_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ncl.T.cln5_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.225G&#x0003e;A</td>
                    <td headers="hd_h_ncl.T.cln5_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp75Ter</td>
                    <td headers="hd_h_ncl.T.cln5_pathogenic_variants_discussed_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/5729771">NM_006493.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/5729772">NP_006484.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.cln5_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1175_1176delAT</td>
                    <td headers="hd_h_ncl.T.cln5_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr392Ter</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The normal protein comprises 407 amino acids.</p>
            <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">CLN5</italic> is a lysosomal transmembrane or soluble protein of unknown function.</p>
          </sec>
          <sec id="ncl.CLN6">
            <title>
              <italic toggle="yes">CLN6</italic>
            </title>
            <p><bold>Gene structure.</bold> The gene comprises seven exons.</p>
            <p><bold>Pathogenic variants.</bold> More than 60 pathogenic variants are known, including missense and nonsense variants, small deletions or insertions, and splice site variants. Affected individuals have been identified in many countries. The pathogenic variant p.Glu72Ter is common in persons from Costa Rica. The 1-bp insertion c.316dupC is associated with families from Pakistan; p.Ile154del may be common in Portugal. See <xref ref-type="table" rid="ncl.T.cln6_pathogenic_variants_discussed">Table 10</xref>.</p>
            <table-wrap id="ncl.T.cln6_pathogenic_variants_discussed" orientation="portrait" position="anchor">
              <label>Table 10. </label>
              <caption>
                <p><italic toggle="yes">CLN6</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.214G&#x0003e;T</td>
                    <td headers="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu72Ter</td>
                    <td headers="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/8923531">NM_017882.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/8923532">NP_060352.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.316dupC<break/>(c.316insC)</td>
                    <td headers="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg106ProfsTer6</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.460_462delATC</td>
                    <td headers="hd_h_ncl.T.cln6_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile154del</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="ncl.TF.10.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> This transmembrane protein of unknown function resides in the endoplasmic reticulum (ER) [<xref ref-type="bibr" rid="ncl.REF.mole.2004.399">Mole et al 2004</xref>].</p>
            <p><bold>Abnormal gene product.</bold>
<xref ref-type="bibr" rid="ncl.REF.heine.2004.22347">Heine et al [2004]</xref> discuss the defective endoplasmic reticulum resulting from <italic toggle="yes">CLN6</italic> pathogenic variants.</p>
          </sec>
          <sec id="ncl.MFSD8">
            <title>
              <italic toggle="yes">MFSD8</italic>
            </title>
            <p><bold>Gene structure.</bold> The gene comprises 13 exons.</p>
            <p><bold>Pathogenic variants.</bold> More than 30 pathogenic variants are known. Variants in <italic toggle="yes">MFSD8</italic> were originally identified in persons of Turkish origin; cases from many countries have since been described. The most common pathogenic variant is p.Thr294Lys, which is associated with Roma Gypsies originating from the Czech Republic. Another common pathogenic variant is c.754+2T&#x0003e;A. See <xref ref-type="table" rid="ncl.T.mfsd8_pathogenic_variants_discusse">Table 11</xref>.</p>
            <table-wrap id="ncl.T.mfsd8_pathogenic_variants_discusse" orientation="portrait" position="anchor">
              <label>Table 11. </label>
              <caption>
                <p><italic toggle="yes">MFSD8</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ncl.T.mfsd8_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_ncl.T.mfsd8_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ncl.T.mfsd8_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.881C&#x0003e;A&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_ncl.T.mfsd8_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr294Lys</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ncl.T.mfsd8_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.754+2T&#x0003e;A&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_ncl.T.mfsd8_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">(predicted altered splicing)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="ncl.TF.11.1">
                  <label>1. </label>
                  <p>
                    <xref ref-type="bibr" rid="ncl.REF.kousi.2009.810">Kousi et al [2009]</xref>
                  </p>
                </fn>
                <fn id="ncl.TF.11.2">
                  <label>2. </label>
                  <p>
                    <xref ref-type="bibr" rid="ncl.REF.siintola.2007.136">Siintola et al [2007]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> MFSD8 is a member of the major facilitator superdomain family of transporter proteins.</p>
            <p><bold>Abnormal gene product.</bold> Unknown</p>
          </sec>
          <sec id="ncl.CLN8">
            <title>
              <italic toggle="yes">CLN8</italic>
            </title>
            <p><bold>Gene structure.</bold> The gene comprises three exons.</p>
            <p><bold>Pathogenic variants.</bold> More than 20 pathogenic variants are known. Many variants have been reported in persons from several countries, including Turkey and Italy.</p>
            <p>One group of individuals of Finnish origin, who are homozygous for the missense variant p.Arg24Gly, have the allele-specific disease Northern epilepsy/EPMR disease [<xref ref-type="bibr" rid="ncl.REF.ranta.2001">Ranta et al 2001</xref>]. Other pathogenic variants in <italic toggle="yes">CLN8</italic> give rise to the vLINCL phenotype.</p>
            <table-wrap id="ncl.T.cln8_pathogenic_variants_discussed" orientation="portrait" position="anchor">
              <label>Table 12. </label>
              <caption>
                <p><italic toggle="yes">CLN8</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ncl.T.cln8_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_ncl.T.cln8_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_ncl.T.cln8_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ncl.T.cln8_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.70C&#x0003e;G</td>
                    <td headers="hd_h_ncl.T.cln8_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg24Gly</td>
                    <td headers="hd_h_ncl.T.cln8_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/148277059">NM_018941.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/31083053">NP_061764.2</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> This protein of 286 amino acids is localized to the ER and ER Golgi intermediate compartment.</p>
            <p><bold>Abnormal gene product.</bold> Unknown</p>
          </sec>
          <sec id="ncl.CTSD_previously_CLN10">
            <title><italic toggle="yes">CTSD</italic> (previously <italic toggle="yes">CLN10</italic>)</title>
            <p><bold>Gene structure.</bold> The transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001909.4">NM_001909.4</ext-link> comprises nine exons.</p>
            <p><bold>Pathogenic variants.</bold> Seven pathogenic variants are known. None is common (see <related-object source-id="gene" document-id="ncl" object-id="ncl.molgen.TA">Table A</related-object>, <bold>Locus Specific</bold>).</p>
            <p><bold>Normal gene product.</bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001900.1">NP_001900.1</ext-link> has 412 amino acid residues that encode cathepsin D light chain, a lysosomal aspartate protease<bold>.</bold></p>
            <p><bold>Abnormal gene product.</bold> Unknown</p>
          </sec>
          <sec id="ncl.GRN">
            <title>
              <italic toggle="yes">GRN</italic>
            </title>
            <p><bold>Gene structure.</bold> Transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002087.2">NM_002087.2</ext-link> has 13 exons.</p>
            <p><bold>Pathogenic variants.</bold> Two NCL-causing variants have been described [<xref ref-type="bibr" rid="ncl.REF.smith.2012.1102">Smith et al 2012</xref>] (see <related-object source-id="gene" document-id="ncl" object-id="ncl.molgen.TA">Table A</related-object>, <bold>Locus Specific</bold>).</p>
            <p><bold>Normal gene product.</bold> Granulins are a family of secreted, glycosylated peptides that are cleaved from a single precursor protein with 7.5 repeats of a highly conserved 12-cysteine granulin/epithelin motif. The 88-kd precursor protein, progranulin, is also called proepithelin [extracted from RefSeq]. Transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002087.2">NM_002087.2</ext-link> encodes a mature peptide of 576 amino acids, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_002078.1">NP_002078.1</ext-link>.</p>
            <p><bold>Abnormal gene product.</bold> A variant on one disease allele only causes late-onset frontotemporal lobe degeneration with TDP-43 inclusions. Variants on both disease alleles cause childhood-onset NCL. The mechanism is unknown.</p>
          </sec>
          <sec id="ncl.ATP13A2">
            <title>
              <italic toggle="yes">ATP13A2</italic>
            </title>
            <p><bold>Gene structure.</bold> The longest transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_022089.2">NM_022089.2</ext-link> has 29 exons and encodes the longest protein isoform. Other transcript variants have been found.</p>
            <p><bold>Pathogenic variants.</bold> One pathogenic variant that results in NCL has been described [<xref ref-type="bibr" rid="ncl.REF.bras.2012.2646">Bras et al 2012</xref>].</p>
            <p><bold>Normal gene product.</bold> The protein product ATP13A2 is a P-type ATPase. The longest isoform <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_071372.1">NP_071372.1</ext-link> has 1180 amino acids.</p>
            <p><bold>Abnormal gene product.</bold> Unknown</p>
          </sec>
          <sec id="ncl.CTSF">
            <title>
              <italic toggle="yes">CTSF</italic>
            </title>
            <p><bold>Gene structure.</bold> The transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003793.3">NM_003793.3</ext-link> comprises 13 exons.</p>
            <p><bold>Pathogenic variants.</bold> Five pathogenic variants have been described [<xref ref-type="bibr" rid="ncl.REF.smith.2013.1417">Smith et al 2013</xref>].</p>
            <p><bold>Normal gene product.</bold> The protein product, cathepsin F, has 484 amino acid residues. Cathepsins are papain family cysteine proteinases that represent a major component of the lysosomal proteolytic system [extracted from RefSeq].</p>
            <p><bold>Abnormal gene product.</bold> Unknown, but enzyme activity is presumably impaired.</p>
          </sec>
          <sec id="ncl.KCTD7">
            <title>
              <italic toggle="yes">KCTD7</italic>
            </title>
            <p><bold>Gene structure.</bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_153033.4">NM_153033.4</ext-link> is the longest transcript variant and comprises four exons.</p>
            <p><bold>Pathogenic variants.</bold> One NCL-causing variant has been described [<xref ref-type="bibr" rid="ncl.REF.staropoli.2012.202">Staropoli et al 2012</xref>].</p>
            <p><bold>Normal gene product.</bold> The gene product, BTB/POZ domain-containing protein KCTD7, is a potassium channel tetramerization domain-containing protein 7.</p>
            <p><bold>Abnormal gene product.</bold> Unknown, but different pathogenic variants cause different diseases.</p>
          </sec>
        </sec>
      </sec>
      <sec id="ncl.References">
        <title>References</title>
        <sec id="ncl.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ncl.Literature_Cited.reflist0">
            <ref id="ncl.REF.aberg.1999.796">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aberg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirveskari</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santavuori</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Lamotrigine therapy in juvenile neuronal ceroid lipofuscinosis.</article-title>
                <source>Epilepsia</source>
                <volume>40</volume>
                <fpage>796</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10368082</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.aberg.2000.1296">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aberg</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Backman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirveskari</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santavuori</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.</article-title>
                <source>Epilepsia</source>
                <volume>41</volume>
                <fpage>1296</fpage>
                <lpage>302</lpage>
                <pub-id pub-id-type="pmid">11051125</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.arsov.2011.566">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arsov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bromhead</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vears</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossette</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajagopalan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDougall</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sofia</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguglia</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meletti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>88</volume>
                <fpage>566</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">21549341</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.b_ckman.2005.25">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000e4;ckman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santavuori</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aberg</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aronen</surname>
                    <given-names>ET</given-names>
                  </name>
                </person-group>
                <article-title>Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis.</article-title>
                <source>J Intellect Disabil Res.</source>
                <year>2005</year>
                <volume>49</volume>
                <fpage>25</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15634309</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.bellizzi.2000.4573">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellizzi</surname>
                    <given-names>JJ</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Widom</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kemp</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Das</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clardy</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>97</volume>
                <fpage>4573</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10781062</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.burneo.2003.841">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burneo</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzniecky</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faught</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Adult-onset neuronal ceroid lipofuscinosis (Kufs disease) with autosomal dominant inheritance in Alabama.</article-title>
                <source>Epilepsia</source>
                <volume>44</volume>
                <fpage>841</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12790899</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.bras.2012.2646">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bras</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2012</year>
                <volume>21</volume>
                <fpage>2646</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">22388936</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.crystal.2004.1131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crystal</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sondhi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackett</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminsky</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worgall</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stieg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Souweidane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenwald</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strybing</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voss</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Hum Gene Ther</source>
                <volume>15</volume>
                <fpage>1131</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">15610613</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.das.1998.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Das</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becerra</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siakotos</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S.</article-title>
                <source>J Clin Invest</source>
                <volume>102</volume>
                <fpage>361</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">9664077</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.gao.2002.324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boustany</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espinola</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotman</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srinidhi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonellis</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donahue</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bronson</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faust</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stout</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haines</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse.</article-title>
                <source>Am J Hum Genet</source>
                <volume>70</volume>
                <fpage>324</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">11791207</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.hartikainen.1999.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hartikainen</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ju</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroziewicz</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarski</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLendon</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suarez</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene.</article-title>
                <source>Mol Genet Metab</source>
                <volume>67</volume>
                <fpage>162</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10356316</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.heine.2004.22347">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heine</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braulke</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>22347</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">15010453</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.hofmann.1999.234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Das</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>KE</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase deficiency.</article-title>
                <source>Mol Genet Metab</source>
                <volume>66</volume>
                <fpage>234</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10191107</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.junaid.1999.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Junaid</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sklower Brooks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pullarkat</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A novel assay for lysosomal pepstatin-insensitive proteinase and its application for the diagnosis of late-infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Clin Chim Acta</source>
                <volume>281</volume>
                <fpage>169</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">10217638</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.kitzm_ller.2008.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kitzm&#x000fc;ller</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haines</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Codlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cutler</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>17</volume>
                <fpage>303</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">17947292</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.kousi.2009.810">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kousi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siintola</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dvorakova</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vlaskova</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topcu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuksel</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gokben</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minassian</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Brain</source>
                <volume>132</volume>
                <fpage>810</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19201763</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.lauronen.1999.360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lauronen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munroe</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;rvel&#x000e4;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Autti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchison</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Rawe</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puranen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;kkinen</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirveskari</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santavuori</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis.</article-title>
                <source>Neurology.</source>
                <year>1999</year>
                <volume>52</volume>
                <fpage>360</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9932957</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.leman.2005.544">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leman</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothberg</surname>
                    <given-names>PG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).</article-title>
                <source>Hum Genet</source>
                <volume>116</volume>
                <fpage>544</fpage>
                <pub-id pub-id-type="pmid">15991331</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.mao.2003.351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>BL</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease.</article-title>
                <source>FEBS Lett</source>
                <volume>555</volume>
                <fpage>351</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14644441</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.mole.2004.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michaux</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Codlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharp</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cutler</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein.</article-title>
                <source>Exp Cell Res</source>
                <volume>298</volume>
                <fpage>399</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">15265688</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.mole.2011">
              <mixed-citation publication-type="book">Mole SE, Williams RE, Goebel HH. <italic toggle="yes">The Neuronal Ceroid Lipofuscinoses (Batten Disease).</italic> 2 ed. Oxford, UK: Oxford University Press; 2011.</mixed-citation>
            </ref>
            <ref id="ncl.REF.munroe.1997.310">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Munroe</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchison</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Rawe</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boustany</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breuning</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Spectrum of mutations in the Batten disease gene, CLN3.</article-title>
                <source>Am J Hum Genet</source>
                <volume>61</volume>
                <fpage>310</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9311735</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.nijssen.2003.574">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nijssen</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceuterick</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teepen</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyynela</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency.</article-title>
                <source>Brain Pathol</source>
                <volume>13</volume>
                <fpage>574</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">14655761</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.noskov_.2011.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Noskov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Str&#x000e1;neck&#x000fd;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmannov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x00159;istoupilov&#x000e1;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bare&#x00161;ov&#x000e1;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iv&#x000e1;nek</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x0016f;lkov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jahnov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Zee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staropoli</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyynel&#x000e4;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijssen</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kmoch</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.</article-title>
                <source>Am J Hum Genet</source>
                <volume>89</volume>
                <fpage>241</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">21820099</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.ostergaard.2011.1245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f8;lgaard</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease).</article-title>
                <source>Neurology</source>
                <volume>76</volume>
                <fpage>1245</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">21464428</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.ramadan.2007.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramadan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Din</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ismail</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Twomey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1.</article-title>
                <source>Neurology</source>
                <volume>68</volume>
                <fpage>387</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17261688</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.ranta.2001">
              <mixed-citation publication-type="book">Ranta S, Savukoski M, Santavuori P, Haltia M. Studies of homogenous populations: CLN5 and CLN8. In: Wisniewski KE, Zhong N, eds. <italic toggle="yes">Batten Disease: Diagnosis, Treatment, and Research</italic> (<italic toggle="yes">Advances in Genetics</italic>, vol 45). San Diego, CA: Academic Press; 2001:123-40</mixed-citation>
            </ref>
            <ref id="ncl.REF.ranta.2004.300">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ranta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topcu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tegelberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ustubutun</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saatci</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enders</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pohl</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alembik</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy.</article-title>
                <source>Hum Mutat</source>
                <volume>23</volume>
                <fpage>300</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15024724</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.riikonen.2000.1828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riikonen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhanen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyynela</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santavuori</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turpeinen</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Neurology</source>
                <volume>54</volume>
                <fpage>1828</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">10802792</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.savukoski.1998.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Savukoski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klockars</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmberg</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santavuori</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Nat Genet</source>
                <volume>19</volume>
                <fpage>286</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9662406</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.schulz.2004.342">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dhar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rylova</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dbaibo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alroy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artacho</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlsch&#x000fc;tter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boustany</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant.</article-title>
                <source>Ann Neurol.</source>
                <volume>56</volume>
                <fpage>342</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">15349861</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.schulz.2013">
              <mixed-citation publication-type="other">Schulz A, Kohlsch&#x000fc;tter A, Mink J, Simonati A, Williams R. NCL diseases - clinical perspectives. Biochim Biophys Acta. 2013;1832:1801-6.</mixed-citation>
            </ref>
            <ref id="ncl.REF.sharp.2003.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sharp</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Hum Mutat</source>
                <volume>22</volume>
                <fpage>35</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">12815591</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.siintola.2007.136">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siintola</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topcu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minassian</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paterson</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>XQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lahtinen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anttonen</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>81</volume>
                <fpage>136</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">17564970</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.sleat.1999.1511">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sleat</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gin</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohar</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sklower-Brooks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pullarkat</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boustany</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uldall</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siakotos</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donnelly</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobel</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder.</article-title>
                <source>Am J Hum Genet</source>
                <volume>64</volume>
                <fpage>1511</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">10330339</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.smith.2012.1102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staropoli</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Strikingly different clinicopathological phenotypes determined by progranulin mutation dosage.</article-title>
                <source>Am J Hum Genet</source>
                <volume>90</volume>
                <fpage>1102</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22608501</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.smith.2013.1417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giaccone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossette</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000f6;tzinger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staropoli</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2013</year>
                <volume>22</volume>
                <fpage>1417</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">23297359</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.staropoli.2012.202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Staropoli</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karaa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elbalalesy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romansky</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leydiker</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coppel</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdenur</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotman</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2012</year>
                <volume>91</volume>
                <fpage>202</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22748208</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.teixeira.2003.502">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teixeira</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espinola</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Persaud Sawin</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minassian</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bessa</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephan</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sa Miranda</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribeiro</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boustany</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Hum Mutat</source>
                <volume>21</volume>
                <fpage>502</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12673792</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.van_diggelen.2001.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thobois</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilikete</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabot</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keulemans</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bunderen</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Losekoot</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voznyi</surname>
                    <given-names>YV</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease.</article-title>
                <source>Ann Neurol</source>
                <volume>50</volume>
                <fpage>269</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">11506414</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.verity.2010.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verity</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winstone</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stellitano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Will</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicoll</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The epidemiology of progressive intellectual and neurological deterioration in childhood.</article-title>
                <source>Arch Dis Child</source>
                <volume>95</volume>
                <fpage>361</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19948513</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.voznyi.1999.471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Voznyi</surname>
                    <given-names>YV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keulemans</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catsman-Berrevoets</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winchester</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants.</article-title>
                <source>J Med Genet</source>
                <volume>36</volume>
                <fpage>471</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10874636</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.weleber.1998.580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weleber</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses.</article-title>
                <source>Eye</source>
                <volume>12</volume>
                <fpage>580</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">9775220</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.williams.2012.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses.</article-title>
                <source>Neurology</source>
                <volume>79</volume>
                <fpage>183</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">22778232</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.wi_niewski.1999.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wi&#x0015b;niewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kida</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connell</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarski</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalewski</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroziewicz</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations.</article-title>
                <source>Mol Genet Metab</source>
                <volume>66</volume>
                <fpage>248</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">10191110</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.wi_niewski.1998a.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wi&#x0015b;niewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarski</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kida</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarz</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazzarini</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubin</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stenroos</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <year>1998a</year>
                <article-title>Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis.</article-title>
                <source>Ann Neurol</source>
                <volume>43</volume>
                <fpage>106</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9450775</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.wi_niewski.1998b.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wi&#x0015b;niewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarski</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sklower-Brooks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>WT</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>Studies of atypical JNCL suggest overlapping with other NCL forms.</article-title>
                <source>Pediatr Neurol</source>
                <volume>18</volume>
                <fpage>36</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">9492089</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.wi_niewski.2001.576">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wi&#x0015b;niewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippart</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Pheno/genotypic correlations of neuronal ceroid lipofuscinoses.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>576</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11548735</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.zhong.2000a.312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroziewicz</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ju</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkiewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>WT</given-names>
                  </name>
                </person-group>
                <year>2000a</year>
                <article-title>Heterogeneity of late-infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Genet Med</source>
                <volume>2</volume>
                <fpage>312</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11339651</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.zhong.1998.234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartikainen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ju</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroziewicz</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLendon</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sklower Brooks</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>WT</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis.</article-title>
                <source>Clin Genet</source>
                <volume>54</volume>
                <fpage>234</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9788728</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.zhong.2000b.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ju</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroziewicz</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkiewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLendon</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>WT</given-names>
                  </name>
                </person-group>
                <year>2000b</year>
                <article-title>Molecular diagnosis of and carrier screening for the neuronal ceroid lipofuscinoses.</article-title>
                <source>Genet Test</source>
                <volume>4</volume>
                <fpage>243</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11142754</pub-id>
              </element-citation>
            </ref>
            <ref id="ncl.REF.zupanc.2004.156">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zupanc</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legros</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Progressive myoclonic epilepsy.</article-title>
                <source>Cerebellum</source>
                <volume>3</volume>
                <fpage>156</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15543806</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ncl.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ncl.Author_Notes">
          <title>Author Notes</title>
          <p>The original author, Dr. Wi&#x0015b;niewski, was a nationally and internationally known pediatric neurologist and neuropathologist/neurobiologist. She was the author or co-author of more than 300 publications and numerous books and book chapters in the field of progressive neurogenetic diseases and intellectual and developmental disabilities.</p>
          <p>Current author, Sara Mole PhD, is a research scientist with more than 20 years&#x02019; experience in the neuronal ceroid lipofuscinoses. She curates the NCL Mutation Database, part of the NCL Resource web site, and is an author of many scientific articles, reviews and book chapters, including editor of a book on Batten disease.</p>
          <p>Current author, Ruth Williams MD, is a pediatric neurologist specializing in epilepsy, with many years of special interest in the NCLs.</p>
        </sec>
        <sec id="ncl.Author_History">
          <title>Author History</title>
          <p>Sara E Mole, PhD (2010-present)Ruth E Williams, MD (2010-present)Krystyna E Wi&#x0015b;niewski, MD, PhD; New York State Institute for Basic Research in Developmental Disabilities (2001-2010)</p>
        </sec>
        <sec id="ncl.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>1 August 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>2 March 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>17 May 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>15 August 2005 (bp) Revision: sequence analysis for CLN5 and CLN8 clinically available</p>
            </list-item>
            <list-item>
              <p>19 November 2004 (bp) Revision: <italic toggle="yes">CLN5</italic> and <italic toggle="yes">CLN8</italic> sequence analysis</p>
            </list-item>
            <list-item>
              <p>27 January 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>12 June 2003 (kw) Revision: testing</p>
            </list-item>
            <list-item>
              <p>10 October 2001 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 February 2001 (kw) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
